Lunit to Supply AI-Powered Imaging Solutions to Saudi Arabia's Ministry of National Guard Health Affairs

Lunit INSIGHT CXR and MMG to be integrated into existing medical imaging workflows through solutions by stc

SEOUL, South Korea, Nov. 9, 2026 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that it will supply its AI-powered medical imaging solutions, Lunit INSIGHT CXR and Lunit INSIGHT MMG, to Saudi Arabia's Ministry of National Guard Health Affairs (MNGHA), a major government healthcare system.

The deployment will be carried out through solutions by stc, an information and communications technology (ICT) subsidiary of Saudi Arabia's stc Group, which will serve as the systems integrator for the project. Lunit will provide licenses for Lunit INSIGHT CXR, its AI-powered chest X-ray analysis solution, and Lunit INSIGHT MMG, its AI-powered mammography analysis solution. Both solutions will be integrated into MNGHA's existing Picture Archiving and Communication System (PACS), enabling healthcare professionals to access AI-generated analysis results within their existing medical imaging workflows.

Established in 1982, MNGHA operates under Saudi Arabia's Ministry of National Guard, providing healthcare services to National Guard personnel, their families, and the general public. The organization operates an extensive network of hospitals and medical centers across Saudi Arabia, including major facilities in Riyadh and Jeddah.

MNGHA is also recognized for its advanced digital healthcare infrastructure. In 2022, King Abdulaziz Medical City in Riyadh, one of MNGHA's major medical facilities, became the first healthcare institution worldwide to achieve the highest level, Stage 7, across four HIMSS digital maturity assessment models, demonstrating its capabilities in healthcare digitalization.

The agreement builds on Lunit's growing presence in Saudi Arabia. In 2023, Lunit participated in initiatives involving SEHA Virtual Hospital and the Healthcare Sandbox program as part of Saudi Arabia's Vision 2030 digital healthcare transformation efforts. That same year, Lunit also entered into an agreement to supply Lunit INSIGHT CXR and Lunit INSIGHT MMG to Dr. Sulaiman Al Habib Medical Group, one of the country's largest private healthcare providers.

"MNGHA has established one of the most advanced digital healthcare infrastructures, and this deployment reflects the capabilities of our AI solutions and their ability to integrate into large-scale healthcare systems," said Brandon Suh, CEO of Lunit. "Through our collaboration with solutions by stc, we aim to further strengthen our presence in Saudi Arabia and expand access to AI-powered cancer screening across the Middle East."

About Lunit

Founded in 2013, Lunit (KRX: 328130) is a global leader on a mission to conquer cancer through AI. Our clinically validated solutions span medical imaging, breast health, and biomarker analysis, empowering earlier detection, smarter treatment decisions, and more precise outcomes across the cancer care continuum.

Lunit offers a comprehensive suite spanning risk prediction and early detection to precision oncology. Our FDA-cleared Lunit INSIGHT Breast Suite and breast health solutions support cancer screening in thousands of medical institutions worldwide, while the Lunit SCOPE platform is used in research partnership with global pharma and laboratory leaders for biomarker research, and companion diagnostic development.

Trusted by over 10,000 sites in more than 65 countries, Lunit combines deep medical expertise with continuously evolving datasets to deliver measurable impact for patients, clinicians, and researchers alike. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at lunit.io.

SOURCE Lunit